Parkinson's disease (PD) is a progressive neurodegenerative disorder caused mainly by
lack of dopamine in the brain. Dopamine is a neurotransmitter involved in movement …

Misfolding and aggregation of alpha‐synuclein (α‐synuclein) with concomitant cytotoxicity is
a hallmark of Lewy body related disorders such as Parkinson's disease, dementia with Lewy …

Evolving concepts on Parkinson's disease (PD) pathology suggest that α-synuclein (aSYN)
promote dopaminergic neuron dysfunction and death through accumulating in the …

Accumulation of pathological α-synuclein aggregates plays a major role in Parkinson's
disease. Macroautophagy is a mechanism to degrade intracellular protein aggregates by …

The blood platelet plays an important role but often remains under‐recognized in several
vascular complications and associated diseases. Surprisingly, platelet hyperactivity and …

Dementia with Lewy bodies (DLB) is a complex disease that involves a variety of cognitive,
behavioral and neurological symptoms, including progressive memory loss, visual …

The overwhelming success of exome-and genome-wide association studies in discovering
thousands of disease-associated genes necessitates develo** novel high-throughput …

One of the comorbid conditions in an individual with Alzheimer's disease is a sleep disorder.
Clinical features of sleep disorders involve various sleep disturbances such as Obstructive …

Parkinson's disease (PD) is the second-most-common neurodegenerative disease
characterized by motor and non-motor dysfunctions, which currently affects about 10 million …

Parkinson's disease (PD) is the second most common neurodegenerative disorder
characterized by loss of dopaminergic (DAergic) neurons in the substantia nigra (SN) that …